Business Standard

Global indices cheer as Moderna's Covid vaccine data boost sentiment

Development on Moderna's candidate, recovery in Asia, corporate earnings propel markets towards fresh highs

markets, stock market, sensex, correction, nifty, shares, growth, profit, economy, gain
Premium

The Dow Jones Industrial Average rose 374.49 points, or 1.27 per cent, as of 8:58 pm (IST), to 29,854.30. The S&P 500 opened higher by 34.32 points, or 0.96 per cent to 3,619.47

Reuters London
Global stocks eyed a fresh record high on Monday as signs of economic recovery in Asia, strong corporate earnings, and additional positive data about a Covid-19 vaccine boosted investor sentiment. Moderna Inc's experimental vaccine was 94.5 per cent effective in preventing Covid-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second US drugmaker to report results that far exceed expectations.

Wall Street opened higher on Monday. The Dow Jones Industrial Average rose 374.49 points, or 1.27 per cent, as of 8:58 pm (IST), to 29,854.30. The S&P 500 opened higher by 34.32 points, or

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in